Phase I and pharmacokinetic study of prinomastat, a matrix metalloprotease inhibitor.

Hande KR, Collier M, Paradiso L, Stuart-Smith J, Dixon M, Clendeninn N, Yeun G, Alberti D, Binger K, Wilding G
Clin Cancer Res. 2004 10 (3): 909-15

PMID: 14871966 · DOI:10.1158/1078-0432.ccr-0981-3

MeSH Terms (17)

Adult Aged Aged, 80 and over Alkaline Phosphatase Antineoplastic Agents Area Under Curve Disease Progression Enzyme Inhibitors Female Humans Kinetics Male Matrix Metalloproteinase Inhibitors Maximum Tolerated Dose Middle Aged Organic Chemicals Time Factors

Connections (1)

This publication is referenced by other Labnodes entities: